| 1 |
Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 [J]. Eur Respir J, 2019, 53(5). pii: 1900164.
|
| 2 |
廖清, 陶玉坚. 慢性阻塞性肺疾病流行病学及危险因素研究现状 [J/CD]. 中华临床医师杂志(电子版), 2018, 12(8): 468-471.
|
| 3 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study [J]. Lancet, 2018, 391(10131): 1706-1717.
|
| 4 |
Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease [J]. N Engl J Med, 2019, 381(13): 1257-1266.
|
| 5 |
Rabe KF, Watz H. Chronic obstructive pulmonary disease [J]. Lancet, 2017, 389(10082): 1931-1940.
|
| 6 |
Li T, Hu R, Chen Z, et al. Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China [J]. Chron Dis Transl Med, 2018, 4(3): 176-186.
|
| 7 |
Lipworth B, Kuo CR, Jabbal S. Current appraisal of single inhaler triple therapy in COPD [J]. Int J Chron Obstruct Pulmon Dis, 2018, 13: 3003-3009.
|
| 8 |
Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels [J]. N Engl J Med, 2013, 368(26): 2455-2466.
|
| 9 |
Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD [J]. Eur Respir J, 2015, 45(4): 879-905.
|
| 10 |
McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev, 2015(2): CD003793.
|
| 11 |
Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation [J]. Am J Respir Crit Care Med, 2013, 188(8): e13-e64.
|
| 12 |
尹正录, 孟兆祥, 王继兵, 等. 肺康复对慢性阻塞性肺疾病稳定期患者BODE指数和血清炎症因子的影响 [J/CD]. 中华临床医师杂志(电子版), 2019, 13(7): 521-526.
|
| 13 |
Spruit MA, Pitta F, McAuley E, et al. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2015, 192(8): 924-933.
|
| 14 |
Güell MR, Cejudo P, Ortega F, et al. Benefits of long-term pulmonary rehabilitation maintenance program in patients with severe chronic obstructive pulmonary disease. Three-year follow-up [J]. Am J Respir Crit Care Med, 2017, 195(5): 622-629.
|
| 15 |
Zhang HL, Li JS, Yu XQ, et al. An evaluation of activity tolerance, patient-reported outcomes and satisfaction with the effectiveness of pulmonary Daoyin on patients with chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 2333-2342.
|
| 16 |
张盼奎. 呼吸导引操治疗慢性阻塞性肺疾病稳定期患者的疗效初步评价 [D]. 郑州: 河南中医药大学,河南中医学院, 2013.
|
| 17 |
张文青. 中医康复技术应用于慢性阻塞性肺疾病稳定期的初步研究 [D]. 广东: 广州中医药大学, 2012.
|
| 18 |
于杰, 孙忠人, 常惟智, 等. 导引术作用机制及临床应用 [J]. 山东中医药大学学报, 2016, 40(2): 105-109.
|
| 19 |
Chen X, Cui J, Li R, et al. Dao Yin (a.k.a. Qigong): Origin, Development, Potential Mechanisms, and Clinical Applications [J]. Evid Based Complement Alternat Med, 2019, 2019: 3705120.
|
| 20 |
谢林艳, 孟殿怀, 许光旭, 等. 太极拳在治疗稳定期慢性阻塞性肺疾病中的作用 [J]. 中华物理医学与康复杂志, 2016, 38(9): 713-716.
|
| 21 |
李涛, 胡蓉, 陈子, 等. 八段锦治疗稳定期慢性阻塞性肺疾病的价值及其应用 [J]. 中华物理医学与康复杂志, 2018, 40(2): 158-160.
|
| 22 |
谢林艳, 葛林阳, 李涛, 等. 六字诀治疗慢阻肺的价值及其应用 [J]. 中华物理医学与康复杂志, 2020, 42(3): 285-288.
|
| 23 |
Yu F, Xin M, Liu N, et al. The Qigong Wuqinxi for chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis [J]. Medicine (Baltimore), 2019, 98(30): e16633.
|
| 24 |
Yu XQ, Li JS, Li SY, et al. Functional and psychosocial effects of pulmonary Daoyin on patients with COPD in China: study protocol of a multicenter randomized controlled trial [J]. J Integr Med, 2013, 11(2): 140-146.
|
| 25 |
廉书献. 中医呼吸导引康复技术对COPD稳定期患者肺功能的影响 [J]. 临床研究, 2019, 27(1): 110-111.
|
| 26 |
吉瑛瑛, 龚彩霞, 黄笑娟, 等. 呼吸康复训练结合中医呼吸导引对COPD患者肺功能及运动功能的影响 [J]. 云南中医中药杂志, 2018, 39(10): 23-26.
|